Growth Metrics

Cytosorbents (CTSO) Assets Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -20.12%
Dec 31, 2025 -6.73%
Sep 30, 2025 -4.30%
Jun 30, 2025 -10.18%
Mar 31, 2025 7.88%
Dec 31, 2024 -10.55%
Sep 30, 2024 0.48%
Jun 30, 2024 1.87%
Mar 31, 2024 -18.09%
Dec 31, 2023 -16.25%
Sep 30, 2023 -23.60%
Jun 30, 2023 -26.35%
Mar 31, 2023 -30.99%
Dec 31, 2022 -29.37%
Sep 30, 2022 -34.50%
Jun 30, 2022 -27.48%
Mar 31, 2022 -4.81%
Dec 31, 2021 -0.48%
Sep 30, 2021 -8.84%
Jun 30, 2021 99.34%
Mar 31, 2021 97.80%
Dec 31, 2020 228.50%
Sep 30, 2020 263.57%
Jun 30, 2020 72.94%
Mar 31, 2020 42.69%
Dec 31, 2019 -19.93%
Sep 30, 2019 -16.25%
Jun 30, 2019 -18.49%
Mar 31, 2019 9.51%
Dec 31, 2018 41.88%
Sep 30, 2018 54.15%
Jun 30, 2018 58.22%
Mar 31, 2018 241.45%
Dec 31, 2017 148.65%
Sep 30, 2017 104.63%
Jun 30, 2017 73.76%
Mar 31, 2017 -12.86%
Dec 31, 2016 -13.87%
Dec 31, 2015 32.89%
Dec 31, 2014 109.32%
Sep 30, 2014 138.34%
Jun 30, 2014 277.62%
Mar 31, 2014 390.48%
Dec 31, 2013 21.15%
Sep 30, 2013 23.58%
Jun 30, 2013 2.93%
Mar 31, 2013 -9.25%
Dec 31, 2012 57.33%
Sep 30, 2012 11.38%
Jun 30, 2012 -25.02%
Dec 31, 2011 17.14%